ConductScience.org, home

Paper1756535

Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.

Rutten VP and 7 others. Cancer Immunol Immunother, 1991. Cited by 11 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls. Papers, record 1756535. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1756535

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy of bovine ocular squamous cell carcinoma by repeated intralesional injections of live bacillus Calmette-Guérin (BCG) or BCG cell walls.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.52
iCite
Revised in PubMed
2024-04-26
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rutten VPV P
2Klein WRW R
3De Jong WAW A
4Misdorp WW
5Steerenberg PAP A
6De Jong WHW H
7Den Otter WW
8Ruitenberg EJE J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Carcinoma, Squamous CellMajor topic
Cattle DiseasesMajor topic
Eye NeoplasmsMajor topic
Immunotherapy, ActiveMajor topic
Animals
Cattle
Cell Wall
Female
Hypersensitivity, Delayed
Injections, Intralesional

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13851702Clinico-pathological aspects of immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma.Cancer Immunol Immunother1985https://conductscience.org/library/papers/3851702PubMed
23633215Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3633215PubMed
33892049The use of bacillus Calmette-Guerin in the therapy of bladder carcinoma in situ.J Urol1985https://conductscience.org/library/papers/3892049PubMed
4793490Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants.Ann N Y Acad Sci1976https://conductscience.org/library/papers/793490PubMed
53719596Immune reactivity in cattle with ocular squamous cell carcinoma after intralesional BCG immunotherapy.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3719596PubMed
66957655Immunotherapy by intralesional injection of BCG cell walls or live BCG in bovine ocular squamous cell carcinoma: a preliminary report.J Natl Cancer Inst1982https://conductscience.org/library/papers/6957655PubMed
73303640Clinical observations on the use of BCG cell wall fraction for treatment of periocular and other equine sarcoids.Vet Rec1987https://conductscience.org/library/papers/3303640PubMed
86997513Bacillus Calmette-Guerin immunotherapy of superficial bladder cancer.J Urol1980https://conductscience.org/library/papers/6997513PubMed
93761438Two courses of intravesical bacillus Calmette-Guerin for transitional cell carcinoma of the bladder.J Urol1986https://conductscience.org/library/papers/3761438PubMed
103546618A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.J Clin Oncol1987https://conductscience.org/library/papers/3546618PubMed
11864757Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine.J Natl Cancer Inst1977https://conductscience.org/library/papers/864757PubMed
12820877Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors.J Urol1976https://conductscience.org/library/papers/820877PubMed
13348035Immunotherapy from malignant disease.Annu Rev Med1978https://conductscience.org/library/papers/348035PubMed
144595311Mycobacterial cell wall components in tumor suppression and regression.Natl Cancer Inst Monogr1973https://conductscience.org/library/papers/4595311PubMed
153981707The management of superficial bladder tumors and carcinoma in situ with intravesical bacillus Calmette-Guerin.J Urol1985https://conductscience.org/library/papers/3981707PubMed
163511285Prognostic value of purified protein derivative skin test and granuloma formation in patients treated with intravesical bacillus Calmette-Guerin.J Urol1986https://conductscience.org/library/papers/3511285PubMed
174076159BCG treatment of periocular sarcoid.Equine Vet J1985https://conductscience.org/library/papers/4076159PubMed
186563941Experimental screening of BCG preparations produced for cancer immunotherapy: safety and immunostimulating and antitumor activity of four consecutively produced batches.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6563941PubMed
20447557Immunotherapy in ocular equine sarcoid.J Am Vet Med Assoc1979https://conductscience.org/library/papers/447557PubMed
212784716Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2784716PubMed

See all 29 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
36844800Limbal Squamous Cell Carcinoma in a Black Baldy Cow: Case Report and Surgical Treatment.Case Rep Vet Med2023https://conductscience.org/library/papers/36844800PubMed
34343536Bacille Calmette-Guérin: An ophthalmic perspective.Surv Ophthalmol2022https://conductscience.org/library/papers/34343536PubMed
17630337Current status of veterinary vaccines.Clin Microbiol Rev2007https://conductscience.org/library/papers/17630337PubMed
8044826Local bacillus Calmette-Guérin therapy for bovine vulval papilloma and carcinoma.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8044826PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1756535

GET https://conductscience.org/api/papers/v1/1756535/references?page=2